At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program.
Location: United States, California, Santa Clara
Employees: 11-50
Total raised: $20M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Illumina V... | illuminaVe... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.11.2020 | Series B | $20M | - |
Mentions in press and media 4
| Date | Title | Description |
| 19.01.2022 | Spatial Omics: The Next Wave in the Biological Research Revolution | Josh Ryu, Chief Technology Officer and Co-founder, Rebus Biosystems For decades, biomedical researchers pursued a reductionist strategy, investigating DNA, RNA, proteins and other cellular players in isolation. These studies have been criti... |
| 22.10.2021 | Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments | James Sutcliffe, CEO at Veta Health Veta Health, a global provider of digital solutions for remote patient care and chronic condition monitoring appoints James Sutcliffe as Chief Executive Officer. Sutcliffe will guide the strategic directi... |
| 01.03.2021 | Rebus Biosystems Launches Automated Spatial Omics Platform | |
| 19.11.2020 | Rebus Biosystems, Inc. Announces $20 Million Series B Financing to Support Commercialization of Automated Spatial Omics Solution |